(VV) Large-Cap Shares - Overview
Etf: Large-Cap, Equity, Index, ETF, US
Dividends
| Dividend Yield | 1.18% |
| Yield on Cost 5y | 1.99% |
| Yield CAGR 5y | 6.81% |
| Payout Consistency | 97.9% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.4% |
| Relative Tail Risk | 5.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | -0.15 |
| Character TTM | |
|---|---|
| Beta | 0.978 |
| Beta Downside | 0.984 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.97% |
| CAGR/Max DD | 1.12 |
Description: VV Large-Cap Shares January 29, 2026
The Vanguard Large-Cap Index Fund ETF (VV) seeks to replicate the CRSP US Large-Cap Index, which covers roughly the top 85 % of U.S. market capitalization. The fund holds the constituent stocks in proportion to their index weights, meaning its portfolio closely mirrors the index composition and is classified as a non-diversified large-blend ETF.
As of the most recent filing (Q4 2025):
• Expense ratio = 0.04 % (among the lowest in the category).
• Assets under management ≈ $120 billion, placing VV in the top 5 U.S. large-cap ETFs by size.
• 30-day SEC yield ≈ 1.8 % (reflecting the current dividend environment for large-cap equities).
• Top sector exposures: Information Technology ≈ 23 %, Health Care ≈ 14 %, Financials ≈ 12 %.
These figures are drawn from Vanguard’s publicly released data and may shift with market movements.
Performance drivers for VV are largely macro-economic. Recent U.S. GDP growth of 2.1 % YoY (Q3 2025) and a Federal Reserve policy rate of 5.25 % support corporate earnings, especially in technology and health-care firms that dominate the index. However, any sustained increase in inflation or a sharp rise in interest rates could compress equity valuations, introducing downside risk to the fund’s return profile.
For a deeper, data-rich assessment of how VV fits within a broader portfolio, you might explore ValueRay’s analytical tools.
What is the price of VV shares?
Over the past week, the price has changed by -0.25%, over one month by -0.51%, over three months by +2.81% and over the past year by +14.79%.
Is VV a buy, sell or hold?
What are the forecasts/targets for the VV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 374.2 | 17.8% |
VV Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 47.72b USD (47.72b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 47.72b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 47.72b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.52% (E(47.72b)/V(47.72b) * Re(9.52%) + (debt-free company))
Discount Rate = 9.52% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)